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Volume 40, Number 6 Cambria 1073ularly at patients with high creatinine levels or renal artery
stenosis, and what the outcome was in those patients insofar as
rise in creatinine concentration. I realize your incidence of renal
failure was low.
The other question is, if you have a patient with a creatinine
concentration of 3, 4 or 5 mg/dL, do you electively use dialysis
before surgery, inasmuch as there may be some virtue in that?
Dr Jacobs. To answer the first question, all patients in our
analysis were mixed, including patients with renal artery stenosis
with normal and with impaired renal function. The message of
TAA repair. It now seems clear that these data reflect inadequatethis presentation, I would say, is that if you perform selective
perfusion it doesn’t make sense to do it without pressure
measurement. Because if you put the 4 catheters in the 4
arteries, the superior mesenteric and celiac access will steal 80%
to 90% of the blood flow to the visceral organs, and you end up
with maybe 50 mL/min to each kidney, and they just cannot
accept that.
With regard to the second question, in patients with severe
renal impairment before the procedure we do not use dialysis
before the operation.INVITED COMMENTARYRichard P. Cambria, MD
Postoperative acute renal failure (ARF) has traditionally been
an important factor in the overall morbidity of thoracoabdominal
aneurysm repair (TAA). There is consensus that when ARF occurs
in this setting overall mortality increases significantly. In our expe-
rience, ARF after TAA increased mortality nearly 7-fold! In addi-
tion, most series that specifically examine the risk for ARF find that
patients with antecedent renal dysfunction are at significantly
higher risk. Thus assessment of renal function and the potential for
correction of concomitant renovascular disease, present in as many
as 40% of patients with TAA, figures prominently in clinical and
intraoperative decision-making.
Jacobs et al1 herein report their technique for selective pres-
sure and flow volume–controlled renal and visceral perfusion for
specific organ protection during TAA repair. The results achieved
are enviable; overall, 7% of their patients sustained clinically signif-
icant ARF with only a 1% (all temporary) rate of dialysis. By way of
historical perspective, the corresponding respective figures in
Crawford’s large series of 1500 patients with TAA were 18% and
9%!2 Recognizing the variant criteria for defining ARF after TAA
repair and that many patients will have a degree of non-oliguric,
self-limited ARF, the authors have categorized postoperative renal
function according to a scheme we previously reported (see their
reference 2). There is striking concordance with their overall data
and those in our report, indicating that regional hypothermic renal
artery perfusion, which has been our preferred approach, remains a
valid protective adjunct. Furthermore, the authors’ data provide an
explanation for the apparent paradoxic, negative effect of warm
blood renal catheter perfusion reported in several large series ofpressure or volume control of such perfusion, rather than an
inherent deficiency of the technique itself. Finally, it is worth
mention that all of the aforementioned protective adjuncts are
directed at limiting the degree and duration of renal ischemia.
Other considerations, such as avoiding atheroembolism, an ag-
gressive posture toward correction of concomitant renovascular
lesions, and precision in the renovascular reconstructive compo-
nents of TAA repair, are important considerations in the preven-
tion of ARF.
The ARF data of Jacobs and colleagues are a lofty benchmark
in TAA surgery. Overall mortality in their patients was 8.6%, nearly
identical to our own and that of other major series. I believe their
method provides for optimal renal protection and thus should be
considered seriously for application in that subset of patients at
particular risk for ARF (ie, those with abnormal renal function). By
extension, antecedent renal dysfunction is a variable that could
sway an overall operative strategy toward a distal perfusion and
selective visceral and renal perfusion technique for surgeons and
patients when such might not otherwise be used. This report will
likely influence the practice of those involved in TAA repair.
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